Ontrak Inc. (OTRK)

$2.26

-0.09

(-3.83%)▲

Market is closed - opens 7 PM, 11 Oct 2024

Performance

  • $2.10
    $2.35
    $2.26
    downward going graph

    7.3%

    Downside

    Day's Volatility :10.85%

    Upside

    3.83%

    downward going graph
  • $1.81
    $21.29
    $2.26
    downward going graph

    19.91%

    Downside

    52 Weeks Volatility :91.5%

    Upside

    89.39%

    downward going graph

Returns

PeriodOntrak Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-35.22%
3.7%
0.0%
6 Months
-59.82%
8.3%
0.0%
1 Year
-79.91%
17.1%
0.0%
3 Years
-99.71%
21.3%
-20.3%

Highlights

Market Capitalization
7.2M
Book Value
$4.82
Earnings Per Share (EPS)
7.35
PE Ratio
0.31
Wall Street Target Price
45.0
Profit Margin
-222.54%
Operating Margin TTM
-165.12%
Return On Assets TTM
-45.18%
Return On Equity TTM
-340.91%
Revenue TTM
12.4M
Revenue Per Share TTM
4.59
Quarterly Revenue Growth YOY
-17.2%
Gross Profit TTM
7.1M
EBITDA
-14.9M
Diluted Eps TTM
7.35
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-7.39
EPS Estimate Next Year
-3.67
EPS Estimate Current Quarter
-0.1
EPS Estimate Next Quarter
-0.1

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Ontrak Inc.(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 1891.15%

Current $2.26
Target $45.00

Company Financials

FY18Y/Y Change
Revenue
15.2M
↑ 96.67%
Net Income
-14.2M
↑ 4.46%
Net Profit Margin
-93.64%
↑ 82.66%
FY19Y/Y Change
Revenue
35.1M
↑ 131.24%
Net Income
-26.2M
↑ 84.13%
Net Profit Margin
-74.56%
↑ 19.08%
FY20Y/Y Change
Revenue
82.8M
↑ 136.04%
Net Income
-22.7M
↓ 13.21%
Net Profit Margin
-27.42%
↑ 47.14%
FY21Y/Y Change
Revenue
84.1M
↑ 1.56%
Net Income
-37.1M
↑ 63.56%
Net Profit Margin
-44.15%
↓ 16.73%
FY22Y/Y Change
Revenue
14.5M
↓ 82.75%
Net Income
-51.6M
↑ 38.85%
Net Profit Margin
-355.33%
↓ 311.18%
FY23Y/Y Change
Revenue
12.7M
↓ 12.2%
Net Income
-27.9M
↓ 45.86%
Net Profit Margin
-219.1%
↑ 136.23%
Q1 FY23Q/Q Change
Revenue
2.5M
↑ 0.0%
Net Income
-9.1M
↓ 19.73%
Net Profit Margin
-362.79%
↑ 89.16%
Q2 FY23Q/Q Change
Revenue
3.0M
↑ 17.93%
Net Income
-6.8M
↓ 25.81%
Net Profit Margin
-228.24%
↑ 134.55%
Q3 FY23Q/Q Change
Revenue
3.7M
↑ 25.51%
Net Income
-6.4M
↓ 5.0%
Net Profit Margin
-172.76%
↑ 55.48%
Q4 FY23Q/Q Change
Revenue
3.5M
↓ 4.74%
Net Income
-6.4M
↓ 0.34%
Net Profit Margin
-180.73%
↓ 7.97%
Q1 FY24Q/Q Change
Revenue
2.7M
↓ 24.27%
Net Income
-4.5M
↓ 30.3%
Net Profit Margin
-166.34%
↑ 14.39%
Q2 FY24Q/Q Change
Revenue
2.5M
↓ 8.54%
Net Income
-10.3M
↑ 130.8%
Net Profit Margin
-419.79%
↓ 253.45%
FY18Y/Y Change
Total Assets
6.3M
↓ 4.25%
Total Liabilities
15.3M
↑ 167.93%
FY19Y/Y Change
Total Assets
23.9M
↑ 277.27%
Total Liabilities
47.8M
↑ 212.43%
FY20Y/Y Change
Total Assets
144.7M
↑ 506.59%
Total Liabilities
84.0M
↑ 75.76%
FY21Y/Y Change
Total Assets
93.7M
↓ 35.26%
Total Liabilities
48.1M
↓ 42.67%
FY22Y/Y Change
Total Assets
25.8M
↓ 72.51%
Total Liabilities
20.1M
↓ 58.28%
FY23Y/Y Change
Total Assets
19.8M
↓ 22.95%
Total Liabilities
5.6M
↓ 72.24%
Q1 FY23Q/Q Change
Total Assets
25.8M
↑ 0.0%
Total Liabilities
20.1M
↑ 0.0%
Q2 FY23Q/Q Change
Total Assets
22.6M
↓ 12.22%
Total Liabilities
21.9M
↑ 8.83%
Q3 FY23Q/Q Change
Total Assets
20.8M
↓ 8.15%
Total Liabilities
25.4M
↑ 16.21%
Q4 FY23Q/Q Change
Total Assets
19.8M
↓ 4.44%
Total Liabilities
5.6M
↓ 78.05%
Q1 FY24Q/Q Change
Total Assets
26.7M
↑ 34.65%
Total Liabilities
5.5M
↓ 1.78%
Q2 FY24Q/Q Change
Total Assets
25.3M
↓ 5.42%
Total Liabilities
9.9M
↑ 80.09%
FY18Y/Y Change
Operating Cash Flow
-8.6M
↑ 16.37%
Investing Cash Flow
62.0K
↓ 115.01%
Financing Cash Flow
7.3M
↓ 37.63%
FY19Y/Y Change
Operating Cash Flow
-16.9M
↑ 97.12%
Investing Cash Flow
-4.6M
↓ 7580.65%
Financing Cash Flow
27.3M
↑ 274.49%
FY20Y/Y Change
Operating Cash Flow
-6.3M
↓ 62.83%
Investing Cash Flow
-4.6M
↑ 0.0%
Financing Cash Flow
100.1M
↑ 266.05%
FY21Y/Y Change
Operating Cash Flow
-26.2M
↑ 316.35%
Investing Cash Flow
-4.5M
↓ 3.41%
Financing Cash Flow
-6.6M
↓ 106.62%
FY22Y/Y Change
Operating Cash Flow
-24.0M
↓ 8.37%
Investing Cash Flow
-1.2M
↓ 74.2%
Financing Cash Flow
-31.1M
↑ 369.32%
Q1 FY23Q/Q Change
Operating Cash Flow
-1.4M
↑ 0.0%
Investing Cash Flow
-98.0K
↓ 35.53%
Financing Cash Flow
-623.0K
↑ 0.0%
Q2 FY23Q/Q Change
Operating Cash Flow
-5.1M
↑ 253.73%
Investing Cash Flow
-98.0K
↑ 0.0%
Financing Cash Flow
3.2M
↓ 618.94%

Technicals Summary

Sell

Neutral

Buy

Ontrak Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ontrak Inc.
Ontrak Inc.
-28.05%
-59.82%
-79.91%
-99.71%
-84.94%
Solventum Corp
Solventum Corp
-1.89%
9.51%
-1.45%
0.12%
-1.45%
Doximity, Inc.
Doximity, Inc.
17.7%
64.08%
94.66%
-38.41%
-18.21%
Veeva Systems Inc.
Veeva Systems Inc.
-7.62%
-0.5%
-3.04%
-26.06%
38.21%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
3.51%
2.9%
33.15%
50.06%
49.2%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ontrak Inc.
Ontrak Inc.
0.32
0.31
NA
-7.39
-3.41
-0.45
NA
4.82
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Doximity, Inc.
Doximity, Inc.
55.0
55.0
2.42
0.9
0.17
0.11
NA
4.92
Veeva Systems Inc.
Veeva Systems Inc.
56.18
56.18
1.17
4.76
0.13
0.06
NA
32.04
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
26.23
26.23
2.38
4.25
0.21
0.06
0.0
17.08
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ontrak Inc.
Ontrak Inc.
Buy
$7.5M
-84.94%
0.32
-222.54%
Solventum Corp
Solventum Corp
Hold
$10.8B
-1.45%
NA
15.73%
Doximity, Inc.
Doximity, Inc.
Hold
$8.2B
-18.21%
55.0
32.53%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$34.0B
38.21%
56.18
23.91%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$41.5B
49.2%
26.23
8.1%

Insights on Ontrak Inc.

  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 3.71M → 2.45M (in $), with an average decrease of 12.5% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -4.45M → -10.28M (in $), with an average decrease of 130.8% per quarter

  • Vs DOCS

    In the last 1 year, Doximity, Inc. has given 94.7% return, outperforming this stock by 174.6%

  • Vs VEEV

    In the last 3 years, Ontrak Inc. has experienced a drawdown of -99.7%, however Veeva Systems Inc. resisted the overall trend and outperformed by 61.3%

Institutional Holdings

  • Geode Capital Management, LLC

    0.22%

  • UBS Group AG

    0.07%

  • State Street Corp

    0.07%

  • Vanguard Group Inc

    0.04%

  • JANE STREET GROUP, LLC

    0.04%

  • BlackRock Inc

    0.03%

Company Information

ontrak, inc. operates as an artificial intelligence powered, virtualized outpatient healthcare treatment company that provides in-person or telehealth intervention services to health plans and other third-party payors. its ontrak pre (predict-recommend-engage) platform predicts people whose chronic disease will improve with behavior change, recommends care pathways that people are willing to follow, and engages people who aren't getting the care they need. the company's technology-enabled, ontrak, program is designed to treat health plan members with unaddressed behavioral health conditions that cause or exacerbate chronic medical diseases, such as diabetes, hypertension, coronary artery disease, copd, and congestive heart failure. the ontrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators who address the social and environmental determinants of health. the company

Organization
Ontrak Inc.
Employees
102
CEO
Mr. Brandon H. LaVerne
Industry
Health Services

Discover More

FAQs